Nucoline
Composition :
Each ml NUCOLINE® Injection contain Citicoline soddium equivalent with Citicoline 125 mg
Pharmacology :
Citicoline may increase blood flow and O2 consumption in the brain in the treatment of cerebrovascular disorders so as to correct impaired consciousness. Citicoline has a working mechanism by:
- Increases the formation reticularis from brain stem, especially the activation system of formatio reticularis ascendens associated with consciousness.
- Activated pyramidal system and improve motor system paralysis.
- Increase O2 consumption from brain and improve brain metabolism.
Indication :
- Acute state :
Loss of consciousness due to cerebral trauma and brain surgery.
Accelerated upper extremity rehabilitation in post apopletic hemiplegia patients: patients with relatively mild limb paralysis who appear within a year and are being rehabilitated and are being given oral drug therapy (with drugs that activate cerebral metabolism or improve circulation).
– Chronic state :
Neurological and psychiatric disorders (hemiplegia) resulting from apopleksia, head injury and cerebral surgery.
Dosage :
- For psychological or nervous disorders:
In cases of impaired consciousness in acute stage cerebral infarct: usually given Citicoline 1000 mg once daily I.V. for two weeks.
In post apopletic hemiplegia cases: usually Citicoline 1000 mg is given once daily I.V. for 4 consecutive weeks, and if it appears to be repaired, the administration is continued for another 4 weeks. Intravenous administration should be given slowly.
- Acute state :
250 – 500 mg, 1 – 2 times daily given by drip I.V. or injection I.V.
Usually 100 to 300 mg, 1-2 times daily intravenously or intramuscularly.
The dosage can be adjusted according to the age and condition patient.
Presentation and Registration Number :
NUCOLINE® 500 mg Injection Box, 5 ampoules @ 4 ml; DKL1208018543A1
NUCOLINE® 1000 mg Injection Box, 2 ampoulesl @ 8 ml; DKL1208018543A1
ON MEDICAL PRESCRIPTION ONLY
Categorised in:
This post was written by admin